the other way to do this (as per my post a few months back) is:
ED market of AUD 5.5b x expected market share x a revenue multiple of say 10 = outrageously high potential market cap for LTP.
What market share should the fastest and most convenient ED product get?
Which ever way you slice it and dice it's huge.
A few milestones need to be meet to get there. My calculation is the odds are well and truely in LTP's favor. Lower dose/side effects, special access in Aus, Aptar etc.
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
40.5¢ |
Change
-0.010(2.41%) |
Mkt cap ! $45.34M | |||
| Open | High | Low | Value | Volume |
| 42.0¢ | 43.5¢ | 39.0¢ | $161.6K | 392.6K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 6 | 150534 | 39.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 40.5¢ | 2000 | 1 |
View Market Depth
| Last trade - 16.10pm 25/07/2025 (20 minute delay) ? |
| LTP (ASX) Chart |